Trust Company’s Insmed INSM Stock Holding History

Trust Company’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$426	Hold	4	–	–	﹤0.01%	795
2026 Q1	$654	Hold	4	–	–	﹤0.01%	650
2025 Q4	$696	Buy	+4	New	+$730	﹤0.01%	604

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Trust Company's INSM Position: Q2 2026 in Review

Trust Company held its Insmed (INSM) position steady in Q2 2026 at 4 shares worth $426. The position accounts for ﹤0.01% of the portfolio, ranked #795.

Trust Company first reported a position in INSM in Q4 2025 and has held it in 3 quarters since. The position peaked at $696 in Q4 2025. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Trust Company held 4 shares of Insmed worth $426 as of Q2 2026.
Trust Company left its Insmed share count unchanged in Q2 2026.
Insmed made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #795 holding.
Trust Company first reported a position in Insmed in Q4 2025 and has held it in 3 quarters since.
Trust Company's Insmed position peaked at $696 in Q4 2025.
663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.